Galena Biopharma Inc news

   Watch this stock
Showing stories 11 - 20 of about 108   

Articles published

GALE 0.300 0.000 (0.00%)
price chart
Don't Miss The True Potential: Galena Biopharma, Inc. (GALE), Superior ...
Galena Biopharma, Inc. (NASDAQ:GALE) popped in on a high volume green day. Volume on 16-Nov-17 came in at 0.65 million contracts.
Galena Biopharma Announces the Resignation of its President and Chief ...
SAN RAMON, Calif., Jan. 31, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical ...
Biopharma CEO exits as pain drug marketing probe deepens  San Francisco Business Times
Galena Biopharma Inc (NASDAQ:GALE) Looks Oversold Right Now  Insider Financial
Hold stock analysis: Galena Biopharma, Inc. (GALE)
Galena Biopharma, Inc. (GALE) stock price traded with surging change along with the volume 0.53 million shares in Friday trading session.
Galena Biopharma reaches $7.5 million accord in US opioid probe
Galena Biopharma Inc has disclosed that it has tentatively agreed to pay $7.5 million to resolve a U.S. Justice Department investigation into its marketing and promotional practices for an opioid-based pain medication.
Galena Biopharma Presents Positive Interim Safety Data on the NeuVax ...
SAN RAMON, Calif., April 04, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced a poster was ...
Galena Biopharma (GALE) vs. Its Peers Head-To-Head Contrast
Galena Biopharma logo Galena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs.
Galena Biopharma (GALE) Says Nasdaq Notified it of Additional 180-day Grace ...
On September 21, 2017, The Nasdaq Stock Market (“Nasdaq”) notified Galena Biopharma, Inc. (the “Company”) that, while the Company had not regained compliance with the minimum bid price requirement, it was eligible for an additional 180-day grace ...
6 hedge funds buy Galena Biopharma, Inc. (GALE) for the first time
Galena Biopharma, Inc. (NASDAQ:GALE) has made a 11.75% comeback from a 12-month low price of $0.26. It was seen -6.18% lower, changing the price to $0.29, when the closing bell rang on 11/10/2017.
Abbott Laboratories (ABT) versus Galena Biopharma (NASDAQ:GALE) Head-To-Head ...
Galena Biopharma logo Galena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs.
The Way Analysts See Galena Biopharma, Inc. (GALE) And Apple Inc. (AAPL)
Galena Biopharma, Inc. (NASDAQ:GALE) traded at an unexpectedly high level on 11/13/2017 when the stock experienced a 0.35% gain to a closing price of $0.29.
Galena Biopharma (NASDAQ:GALE) versus Its Rivals Head-To-Head Contrast  StockNewsTimes
Analyst Opinion Summary: Galena Biopharma, Inc. (GALE), Fidus Investment ...  Analyst Journal